These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35102014)

  • 1. Management of Macrocystic Lymphatic Malformation in the Cervicofacial Region: Ultrasound-Guided Iodine Tincture Cauterization Combined With Intralesional Negative Pressure.
    Han T; Chen H; Cui J; Shen W
    Ann Plast Surg; 2022 Jun; 88(6):e9-e12. PubMed ID: 35102014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflow Occlusion Combined With Bleomycin Sclerotherapy for Management of Macro/Mixed Cystic Lymphatic Malformation in Children.
    Han T; Ji Y; Cui J; Shen W
    Front Pediatr; 2021; 9():749983. PubMed ID: 34631633
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow Pattern Classification in Lymphatic Malformations by Indocyanine Green Lymphography.
    Kato M; Watanabe S; Iida T; Watanabe A
    Plast Reconstr Surg; 2019 Mar; 143(3):558e-564e. PubMed ID: 30817659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
    Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
    Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of an axillary macrocystic lymphatic malformation in a 14-year-old girl using intraoperative indocyanine green lymphography.
    Drobot A; Ganam S; Karra N; Bickel A; Abu Shakra I; Kakiashvili E
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):504-507. PubMed ID: 32325148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children.
    Bajaj Y; Hewitt R; Ifeacho S; Hartley BE
    Int J Pediatr Otorhinolaryngol; 2011 May; 75(5):673-7. PubMed ID: 21419500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Drainage and Povidone-Iodine Sclerotherapy of Cervical Lymphatic Malformation.
    Kim SH; Lee MS; Lim GC; Song CI
    Yonsei Med J; 2017 Nov; 58(6):1249-1251. PubMed ID: 29047253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
    Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
    Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical excision of cervicofacial giant macrocystic lymphatic malformations in infants and children.
    Chen WL; Zhang B; Wang JG; Ye HS; Zhang DM; Huang ZQ
    Int J Pediatr Otorhinolaryngol; 2009 Jun; 73(6):833-7. PubMed ID: 19324424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.
    Shergill A; John P; Amaral JG
    Pediatr Radiol; 2012 Sep; 42(9):1080-8. PubMed ID: 22648390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of efficacy and safety of intralesional injection of high concentration of bleomycin A5 for treatment of huge macrocystic lymphatic malformations in cervical region.
    Xu DP; Zhai QK; Cheng C; Gong H; Wang HW; Wang XK
    J Craniofac Surg; 2014 Sep; 25(5):1707-9. PubMed ID: 25119414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single center experience with intralesional bleomycin sclerotherapy for lymphatic malformations.
    Yılmaz H; Yılmaz Ö; Çamlıdağ İ; Belet Ü; Akan H
    Jpn J Radiol; 2017 Oct; 35(10):590-596. PubMed ID: 28779454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions.
    Merrell SC; Rahbar R; Alomari AI; Padua HM; Vargas SO; Neufeld EJ; Dearden JL; Mulliken JB; Greene AK
    J Craniofac Surg; 2010 Mar; 21(2):422-6. PubMed ID: 20186073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomic distribution of cervicofacial lymphatic malformations based on lymph node groups.
    Sjogren PP; Arnold RW; Skirko JR; Grimmer JF
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():72-75. PubMed ID: 28483255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions.
    Usui H; Shinkai M; Kitagawa N; Mochizuki K; Kawakita I; Tsuzuki Y; Shinohara S; Yagi Y; Masuda M
    Pediatr Surg Int; 2020 Sep; 36(9):1047-1054. PubMed ID: 32661596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of lymphatic dysplasia in patients with congenital pleural effusion and ascites using indocyanine green lymphography.
    Shibasaki J; Hara H; Mihara M; Adachi S; Uchida Y; Itani Y
    J Pediatr; 2014 May; 164(5):1116-1120.e1. PubMed ID: 24518167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocystic lymphatic malformation in the pulmonary parenchyma.
    Schulman JM; Christison-Lagay ER; Kozakewich HP; Boiselle PM; Burrows PE; Fox VL; Fishman SJ
    Ann Thorac Surg; 2009 May; 87(5):1607-9. PubMed ID: 19379923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.